Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03196245 · ClinicalTrials.gov registry record
NK Cell Mediated Influenza Immunity During Pregnancy
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 94
- Enrollment target
NCT03196245: Clinical Trial study, sponsored by Stanford University.
NCT03196245 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 94 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03196245 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 94 participants
- Enrollment target
Study Summary
Pregnant women have increased morbidity and mortality due to infection with influenza. Changes in T cell function have been proposed as possible mechanisms for this finding. We believe that pregnancy induced changes in NK cell phenotype and function also impact influenza immunity. This study will compare the immune response of pregnant women and controls to TIV influenza vaccination as a surrogate for infection. In addition pregnant women with flu like illness will be enrolled to evaluate changes in immune response following influenza infection as compared to vaccination.
Interventions
- OTHER There is no intervention.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2012-08-14 |
| Est. Completion | 2019-04-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03196245
The ClinicalTrials.gov registry entry for NCT03196245 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 94 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which There is no intervention. is the first listed.
NCT03196245 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03196245 about?
NCT03196245 is a clinical study titled "NK Cell Mediated Influenza Immunity During Pregnancy". Pregnant women have increased morbidity and mortality due to infection with influenza. Changes in T cell function have been proposed as possible mechanisms for this finding. We believe that pregnancy induced changes in NK cell phenotype and function also impact influenza immunity. This study will co...
What is the current status of trial NCT03196245?
This trial is currently terminated. The enrollment target is 94 participants. The study started on 2012-08-14. Estimated completion is 2019-04-01.
What interventions are being tested in trial NCT03196245?
The interventions under investigation include: There is no intervention. (OTHER).
Who is sponsoring clinical trial NCT03196245?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.